Modulation of GSK3β autoinhibition by Thr-7 and Thr-8

Area of Science:

• Molecular Biology
• Cellular Signaling
• Biochemistry

Background:

• Glycogen synthase kinase 3β (GSK-3β) is a key regulator of cellular processes, implicated in various diseases.
• Insulin stimulation typically inactivates GSK-3β via AKT-mediated phosphorylation at Ser-9.
• Understanding GSK-3β regulation is crucial for developing targeted therapies.

Discussion:

• This study identifies novel threonine residues (Thr-7 and Thr-8) within the AKT/PKB substrate motif of GSK-3β.
• These residues are critical for insulin-stimulated Ser-9 phosphorylation and subsequent GSK-3β inactivation in vivo.
• Intestinal cell kinase (ICK) was found to phosphorylate GSK-3β at Thr-7, both in vitro and in vivo.

Key Insights:

• Phosphorylation of Thr-8 partially inhibits GSK-3β activity.
• Phosphorylation of Thr-7 by ICK promotes GSK-3β activity.
• Crucially, Thr-7 phosphorylation overrides the autoinhibitory effect of Ser-9 phosphorylation, revealing a complex regulatory mechanism.

Outlook:

• These findings elucidate novel signaling inputs governing GSK-3β autoinhibition.
• The identified phosphorylation sites offer new avenues for modulating GSK-3β activity.
• Further research could explore the therapeutic potential of targeting these specific regulatory mechanisms in pathological conditions involving GSK-3β dysregulation.